MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
ROCKVILLE, MD, July 31, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
News
Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Affimed Announces an ASCO Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech’s SNK01 NK Cells
Stable disease was observed in three out of seven heavily pretreated patients No dose-limiting toxicities…
Affimed Announces an ASCO Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech’s SNK01 NK Cells
Stable disease was observed in three out of seven heavily pretreated patients No dose-limiting toxicities…
Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer
Designation indicates entry into the U.K.’s Innovative Licensing and Access Pathway (ILAP) NEW HAVEN, Conn. and…
Cidara Therapeutics Provides Update on REZZAYO™ (rezafungin for injection)
Cidara’s U.S. Commercial Partner, Melinta Therapeutics, has Initiated Commercial Launch of REZZAYO™ EMA Regulatory Decision…
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of Shares of its Common Stock
IRVINE, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company”…
The NRP Group and Angelo Gordon Break Ground on Multifamily Development in Prince William County, Virginia
WOODBRIDGE, Va.–(BUSINESS WIRE)–The NRP Group – a vertically integrated, best-in-class developer, builder, and manager of…
DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
Montrouge, France, July 31, 2023 DBV Technologies Receives Feedback from FDA on Design Elements for…
Comcast Business Report Finds Global Cybersecurity Community at a Crossroads as Technology Advancements Accelerate
Cybersecurity Threat Report dissects 23.5 billion attempted cybersecurity attacks against Comcast Business customers – phishing…
Healthcare Delivery Organization Signs Contract for Knightscope Security Robot
Houston Energy Client Renews Contract for Second Year MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$KSCP #SecurityRobot—Knightscope, Inc. [Nasdaq:…
CoinFund Hires Leading Transactional Attorney Dilveer Vahali as Head of Venture Legal
Experienced Attorney to Drive CoinFund’s Legal Deal Strategy and Execution NEW YORK–(BUSINESS WIRE)–#CoinFund–Today CoinFund, a…
Augmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health Assets
CHICAGO–(BUSINESS WIRE)–#augmentedreality–Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has been…
G1 Therapeutics to Participate in Two August Investor Conferences
RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Mobile Veterinary Startup ReadiVet Expands Leadership Team to Accelerate Growth
DALLAS & NASHVILLE–(BUSINESS WIRE)–ReadiVet, a leading provider of in-home veterinary care, announced it has appointed…
AnaptysBio- and GSK-Partnered Immuno-Oncology Agent JEMPERLI (dostarlimab-gxly) plus Chemotherapy Approved in the U.S. for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer
JEMPERLI is the first immuno-oncology treatment approved in the frontline setting for this patient population…
MedAvail Announces 1-for-50 Reverse Stock Split
PHOENIX, Ariz., July 31, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or…
Lowell Farms to Announce Second Quarter 2023 Financial and Operational Results
California cannabis leader to hold earnings call with leadership on August 10, 2023 SALINAS, Calif.,…
Huntress CEO Kyle Hanslovan Recognized on CRN’s 2023 Top 100 Executives List
ELLICOTT CITY, Md., July 31, 2023 (GLOBE NEWSWIRE) — Huntress, the managed security platform for…